What's in store in 2014?

What developments are you hoping to see in 2014? Positive results from practice-changing trials that will have a dramatic effect for patients? New approaches in research that harness Big Data and allow every patient experience to count towards common knowledge? A new focus on the epigenome? Or perhaps, more pragmatically, widespread implementation of the evidence we already have?

In this month's EJC News Focus, Helen Saul asks the Presidents of various cancer societies what they'll be looking out for in the coming year. Graeme Poston (ESSO), Cornelis van de Velde (ECCO), Birgitte Grube (EONS), Martine Piccart (ESMO), Vincenzo Valentini (ESTRO) and Moshe Oren (EACR) give us their predictions for cancer in 2014.